| View |
|
DRP-13185-01
|
Etoposide
|
Eposid
|
20 mg/mL (50mg/2.5mL, 100mg/5mL and 200mg/10mL)
|
Solution for IV Injection
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
31 January 2023
|
22 December 2027
|
| View |
|
DRP-9423-01
|
Zinc
|
Zinfate-OD
|
10 mg/mL (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Syrup (Oral Drops)
|
-
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 January 2023
|
29 December 2025
|
| View |
|
DRP-9568-01
|
Paracetamol
|
Pyrexia 100
|
100 mg/mL
|
Suspension (Oral Drops)
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 January 2023
|
26 February 2026
|
| View |
|
DRP-11151-03
|
Cefuroxime (as axetil)
|
Korcef
|
500 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
30 January 2023
|
08 February 2027
|
| View |
|
DRP-13072-01
|
Epirubicin Hydrochloride
|
Epirub-10
|
10 mg
|
Lyophilized Powder for Injection (IV)
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
30 January 2023
|
25 November 2027
|
| View |
|
DRP-3403-02
|
Montelukast (as Sodium)
|
Montesea-10
|
10 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist
|
Medchem International Limited
|
India
|
Renewal
|
07 July 2024
|
23 November 2029
|
| View |
|
DRP-6009-04
|
Ifosfamide
|
Ifosfaget
|
1 g
|
Powder for Injection (IV)
|
Antineoplastic (Alkylating Agent)
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
17 April 2024
|
17 February 2030
|
| View |
|
DRP-9609-01
|
Carbocisteine
|
Tussis-100
|
100 mg/5 mL
|
Syrup
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 January 2023
|
24 March 2026
|
| View |
|
DRP-10047-02
|
Prednisone
|
Viscort
|
10 mg/5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
08 July 2023
|
07 August 2028
|
| View |
|
DRP-113-04
|
Cloxacillin (as Sodium)
|
Avastoph
|
125 mg/5 mL
|
Powder for Suspension
|
-
|
Novagen Pharmaceutical Co., Inc.
|
Philippines
|
CLIDP Conversion
|
26 January 2023
|
19 June 2025
|
| View |
|
DRP-1216-11
|
LOSARTAN POTASSIUM
|
LOSTAN
|
50 mg
|
Film-Coated Tablet
|
ANGIOTENSIN-2-RECEPTOR BLOCKER
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
08 August 2023
|
30 July 2028
|
| View |
|
DRP-9287-01
|
Ambroxol Hydrochloride
|
Couxol
|
6 mg/mL
|
Syrup (Oral Drops)
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 January 2023
|
16 November 2025
|
| View |
|
DRP-10592-02
|
Paclitaxel
|
Clitax
|
6 mg/mL
|
Solution for I.V. Infusion
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 January 2023
|
26 October 2026
|
| View |
|
DRP-10924-01
|
Tranexamic Acid
|
Tranexam
|
100 mg / mL (500 mg / 5 mL)
|
Solution for Injection (IV)
|
-
|
Union Korea Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
26 January 2023
|
17 December 2026
|
| View |
|
DRP-11560-01
|
Tranexamic Acid
|
Exzamixx
|
100 mg/mL (500 mg/ 5 mL)
|
Solution for Intravenous
(I.V.) Injection
|
-
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
26 January 2023
|
30 March 2027
|
| View |
|
DRP-11803-01
|
Phenylpropanolamine Hydrochloride / Brompheniramine Maleate
|
Sinumine
|
6.25 mg /2 mg per mL
|
Syrup (Drops) Grape Flavor
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 January 2023
|
07 September 2026
|
| View |
|
DRP-12759-01
|
Pregabalin + Mecobalamin
|
Prebacol
|
75 mg/750 mcg
|
Capsule
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 January 2023
|
03 October 2027
|
| View |
|
DRP-13075-01
|
Gemcitabine (as Hydrochloride)
|
Zitabin-200
|
200 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 January 2023
|
28 November 2027
|
| View |
|
DRP-13142-01
|
Telmisartan + Amlodipine (as besilate)
|
Mistacor AM
|
80 mg / 5 mg
|
Tablet
|
-
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 January 2023
|
07 December 2027
|
| View |
|
DRP-11401-03
|
Capecitabine
|
Capetan
|
500mg
|
Film-Coated Tablet
|
-
|
Laboratorio Eczane Pharma S.A.
|
Argentine Republic
|
CLIDP Conversion
|
25 January 2023
|
09 March 2027
|